Antidepressants for preventing postnatal depression

Cochrane Database of Systematic Reviews

Volumn 2018, Issue 4, 2018, Pages

  Molyneaux, Emma ^a   Telesia, Laurence A ^b   Henshaw, Carol ^c   Boath, Elizabeth ^d   Bradley, Eleanor ^e   Howard, Louise M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NORTHWICK PARK HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d STAFFORDSHIRE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF WORCESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BROFAROMINE; CITALOPRAM; DOXEPIN; DULOXETINE; FLUOXETINE; MIANSERIN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PLACEBO; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; VILAZODONE;

CLINICAL EFFECTIVENESS; COGNITIVE BEHAVIORAL THERAPY; COMORBIDITY; COMPARATIVE STUDY; CONSTIPATION; DIZZINESS; DROWSINESS; HEADACHE; HUMAN; HYPOMANIA; MANIA; PEER GROUP; POSTNATAL DEPRESSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; FEMALE;

ANTIDEPRESSIVE AGENTS; DEPRESSION, POSTPARTUM; FEMALE; HUMANS; NORTRIPTYLINE; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SERTRALINE;

EID: 85045572412     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004363.pub3     Document Type: Review

References (43)

1. Gracious BL, Hanusa BH, Wisner KL, Peindl KS, Perel JM. Weight changes in postpartum women with remitted depression. Journal of Clinical Psychiatry 2005;66(3):291-3. 2850071
2. Peindl KS. The use of nortriptyline for prevention of postpartum depression in a high-risk group of women. 152nd Annual Meeting of the American Psychiatric Association, 1999 May 15-20, Washington, DC. 1999. 2850074
3. Peindl KS, Wisner KL. Successful recruitment strategies for women in postpartum mental health trials. Journal of Psychiatric Research 2003;37(2):117-25. 2850073
4. Peindl KS, Wisner KL, Hanusa BH, Peindl KS. Identifying depression in the first postpartum year: Guidelines for office-based screening and referral. Journal of Affective Disorders 2004;80(1):37-44. 2850072
5. Wisner KL. Prevention and treatment of postpartum mood disorders. 152nd Annual Meeting of the American Psychiatric Association, 1999 May 15-20, Washington, DC. 1999. 2850076
6. Wisner KL, Perel JM, Peindl KS, Hanusa BH, Findling RL, Rapport D. Prevention of recurrent postpartum depression: a randomized clinical trial. Journal of Clinical Psychiatry 2001;62(2):82-6. 2850075
7. Gracious BL, Hanusa BH, Wisner KL, Peindl KS, Perel JM. Weight changes in postpartum women with remitted depression. Journal of Clinical Psychiatry 2005;66(3):291-3. 2850078
8. Sunder KR, Wisner KL, Hanusa BH, Perel JM. Postpartum depression recurrence versus discontinuation syndrome: observations from a randomized controlled trial. Journal of Clinical Psychiatry 2004;65(9):1266-8. 2850079
9. Wisner KL, Peindl KS, Perel JM, Hanusa BH, Plontek CM, Findling RL. Sertraline prevents postpartum depression. 156th Annual Meeting of the American Psychiatric Association, May 17-22, San Francisco CA. 2003. 2850080
10. Wisner KL, Perel JM, Peindl KS, Hanusa BH, Piontek CM, Findling RL. Prevention of postpartum depression: a pilot randomized clinical trial. American Journal of Psychiatry 2004;161(7):1290-2. 2850081
11. Appleby L. A controlled study of fluoxetine and cognitive -behavioural counselling in the treatment of postnatal depression. European Psychiatry 1998;13 Suppl 4:178s. 2850084
12. Appleby L, Warner R, Whitton A, Faragher B. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ 1997;314(7085):932-6. 2850083
13. Epperson CN, McDougle CJ, Ward-O'Brien D, Price LH. A controlled study of antidepressant treatment of postpartum depression. 149th Annual Meeting of the American Psychiatric Association; 1996 May 4-9; New York, NY. 1996. 7966025
14. Heath AC, Yonkers KA, Rush AJ. Paroxetine in the treatment of postpartum depression. 153rd Annual Meeting of the American Psychiatric Association, 2000 May 13-18, Chicago, (IL). 2000. 2850088
15. Fischer RL, Simpkins GK. Prophylactic Use of Postpartum Sertraline to Prevent Postpartum Depression. clinicaltrials.gov/ct2/show/NCT02235064 (accessed 30 October 2017). [NCT02235064]7966027
16. Sharp D. Antidepressant drug therapy vs a community-based psychosocial intervention for the treatment of moderate postnatal depression: a pragmatic randomised controlled trial. National Research Register 2004. 2850090
17. Wisner K. Sertraline for the Prevention of Recurrent Postpartum Depression [Prevention of Recurrent Postpartum Depression]. clinicaltrials.gov/ct2/show/NCT00276900 2006. 2850092
18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: American Psychiatry Association, 2013.
19. Bland JM, Altman DG. The odds ratio. BMJ 2000;320(7247):1468.
20. Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC, et al. Relapse of Major Depression During Pregnancy in Women Who Maintain or Discontinue Antidepressant Treatment. JAMA 2006;295(5):499.
21. Cox J, Connor Y, Kendell RE. Prospective study of the psychiatric disorders of childbirth. British Journal of Psychiatry 1982;140:111-7.
22. Cox JL, Holden J, Sagovsky R. Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale (EPDS). British Journal of Psychiatry 1987;150:782-6.
23. Dennis C-L, Hodnett ED. Psychosocial and psychological interventions for treating postpartum depression. Cochrane Database of Systematic Reviews 2007, Issue 10. [DOI: 10.1002/14651858.CD006116.pub2]
24. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
25. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. Antidepressant Drug Effects and Depression Severity. A Patient-Level Meta-analysis. JAMA 2010;303(1):47-53.
26. Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003;361(9358):653-61.
27. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
28. Howard LM, Boath E, Henshaw C. Antidepressant Prevention of Postnatal Depression. PLOS Medicine 2006;3(10):e389.
29. Howard LM, Molyneaux E, Dennis C-L, Rochat T, Stein A, Milgrom J. Non-psychotic mental disorders in the perinatal period. Lancet 2014;384(9956):1775-88.
30. Khalifeh H, Hunt IM, Appleby L, Howard LM. Suicide in perinatal and non-perinatal women in contact with psychiatric services: 15 year findings from a UK national inquiry. Lancet Psychiatry 2016;3(3):233-42.
31. Molenaar NM, Brouwer ME, Bockting CL, Bonsel GJ, van der Veere CN, Torij HW, et al. Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial. BMC Psychiatry 2016;16:72. [DOI: 10.1186/s12888-016-0752-6]
32. Molyneaux E, Howard LM, McGeown HR, Karia AM, Trevillion K. Antidepressant treatment for postnatal depression. Cochrane Database of Systematic Reviews 2014, Issue 9. [DOI: 10.1002/14651858.CD002018.pub2]
33. Morrell CJ, Sutcliffe P, Booth A, Stevens J, Scope A, Stevenson M, et al. A systematic review, evidence synthesis and meta-analysis of quantitative and qualitative studies evaluating the clinical effectiveness, the cost-effectiveness, safety and acceptability of interventions to prevent postnatal depression. Health Technology Assessment (Winchester, England) 2016;20(37):1-414.
34. NICE. Depression: the Treatment and Management of Depression in Adults (Update). NICE clinical guideline 90, 2009.
35. Sharp DJ, Chew-Graham C, Tylee A, Lewis G, Howard L, Anderson I, et al. A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial. Health Technology Assessments 2010;14(43):1-153.
36. Spitzer R, Endicott J, Robins E. Research Diagnostic Criteria; rationale and reliability. Archives of General Psychiatry 1978;35(6):773-82.
37. Stein A, Pearson RM, Goodman SH, Rapa E, Rahman A, McCallum M, et al. Effects of perinatal mental disorders on the fetus and child. Lancet 2014;384(9956):1800-19.
38. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16.
39. Turner KM, Sharp D, Folkes L, Chew-Graham C. Women's views and experiences of antidepressants as a treatment for postnatal depression: a qualitative study. Family Practice 2008;25(6):450-5.
40. Wisner KL, Sit DK, McShea MC, Rizzo DM, Zoretich RA, Hughes CL, et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry 2013;70(4):490-8.
41. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guideline. Geneva, World Health Organization, 2004.
42. Yonkers KA, Lin H, Howell HB, Heath AC, Cohen LS. Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine. Journal of Clinical Psychiatry 2008;69(4):659-65.
43. Yonkers KA, Gotman N, Smith MV, Forray A, Belanger K, Brunetto WL, et al. Does antidepressant use attenuate the risk of a major depressive episode in pregnancy?. Epidemiology 2011;22(6):848-54.